|
NISCAIR ONLINE PERIODICALS REPOSITORY (NOPR) >
NISCAIR PUBLICATIONS >
Research Journals >
Journal of Intellectual Property Rights (JIPR) >
JIPR Vol.17 [2012] >
JIPR Vol.17(5) [September 2012] >
| Title: | Drug Prices - How Much is too Much? |
| Authors: | Nair, Manu S |
| Keywords: | Drug price
Drug cost
Affordable drug price
Compulsory license
Drug development
Intellectual property monetization
Biopharma investment
How much is too much
Greed |
| Issue Date: | Sep-2012 |
| Publisher: | NISCAIR-CSIR, India |
| Abstract: | Rising healthcare costs have made drug pricing a controversial issue
worldwide. ‘How much is too much’ is a question that is consistently asked in
this context. While there are several factors contributing to rising drug
prices, strong intellectual property (IP) laws and the efforts of private
sector to monetize such IP are widely blamed for such outcome. Hence, it is important
to have an open discussion on this topic to analyse whether such blame is
justified. An effort is made herein to perform a concise business review to
shed light on the market realities around drug pricing and the important role
that a strong IP landscape plays in driving innovation, quality and sustained
growth of healthcare economy. |
| Page(s): | 497-500 |
| CC License: |  CC Attribution-Noncommercial-No Derivative Works 2.5 India |
| ISSN: | 0975-1076 (Online); 0971-7544 (Print) |
| Source: | JIPR Vol.17(5) [September 2012]
|
|
